D. Inactivating MEN1 tumor-suppressor mutation affecting menin
Why this is correct
Multiple endocrine neoplasia type 1 is an autosomal dominant syndrome caused by germline loss-of-function variants in MEN1, which encodes the tumor suppressor menin. The classic tumor groups are parathyroid hyperplasia/adenomas, pituitary neuroendocrine tumors and pancreatic/duodenal neuroendocrine tumors. Hyperparathyroidism is often the earliest or most penetrant feature. A second somatic hit can inactivate the remaining functional MEN1 allele within a susceptible tumor.
Why each option is correct or incorrect
RET activation is associated with MEN2, medullary thyroid carcinoma and pheochromocytoma, not the classic three MEN1 tumor groups.
Mosaic GNAS activation causes McCune–Albright syndrome and differs from MEN1.
NF1 mutations cause neurofibromatosis type 1 and can associate with pheochromocytoma but not this typical MEN1 pattern.
Correct: MEN1 tumor-suppressor loss underlies the parathyroid, pituitary and pancreatic endocrine tumor combination.
High-yield notes
- MEN1: parathyroid, pituitary and pancreatic/duodenal neuroendocrine tumors.
- MEN1 encodes menin and behaves as a tumor-suppressor gene.
- MEN1 typically follows autosomal dominant inheritance with variable manifestations.
Think MEN1 for hyperparathyroidism plus pituitary adenoma plus pancreatic neuroendocrine tumor.
Distinguish MEN1 (menin tumor suppressor) from MEN2 (activating RET).